In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Year 2015-16 and 2016-17 with the issues involved relating to levy of penalty under section 272A(2)(g) and section 271C of the Income Tax Act, 1961 (“the Act” for short). All the appeals arise from ...

Investors typically turn to dividend-paying stocks and exchange-traded funds (ETFs) to boost their passive income streams so ...

Eli Lilly has raised its revenue guidance for 2024 by $3 billion, after reporting strong growth for tirzepatide in diabetes and obesity, fuelled by the end of supply constraints for starting doses.